Nemanja Todorović
Nemanja Todorović (Serbian Cyrillic: Немања Тодоровић, born 23 April 1991) is a Serbian professional basketball player for Borac Čačak of the Basketball League of Serbia. Standing at 2.06 m (6 ft 9 in), he plays at the power forward position.
No. 34 – Borac Čačak | |
---|---|
Position | Power forward |
League | Basketball League of Serbia |
Personal information | |
Born | Čačak, FR Yugoslavia | April 23, 1991
Nationality | Serbian |
Listed height | 2.06 m (6 ft 9 in) |
Listed weight | 92 kg (203 lb) |
Career information | |
NBA draft | 2013: undrafted |
Playing career | 2010–present |
Career history | |
2010–2013 | Borac Čačak |
2013–2014 | Konstantin |
2014–2015 | Metalac Farmakom |
2015 | Igokea |
2015–2016 | Metalac Farmakom |
2016–2018 | Borac Čačak |
2018–2019 | Lovćen |
2019–present | Borac Čačak |
Professional career
Todorović began his professional career in hometown club Borac Čačak where he played from 2010 until 2013. He then signed with Niš-based club Konstantin. The 2014–15 season he played with Metalac Valjevo. He averaged 5.6 points and 1.8 rebounds in 23 games of the ABA League.
On September 12, 2015, he signed a two-year deal with the Bosnian team Igokea.[1] He debuted for the team in 67–56 loss to Cedevita Zagreb in Round 1 of the ABA League; he contributed with 12 points and 4 rebounds.[2] On December 9, 2015, he left Igokea for his former club Metalac Valjevo, after appearing in 12 games of the ABA League, averaging 5.6 points and 2.8 rebounds.[3] In July 2022, he signed a two-year contract extension with Borac.[4]
References
- "Todorović two seasons with Igokea". abaliga.com. 12 September 2015. Archived from the original on 14 September 2015. Retrieved 12 September 2015.
- "ABA: Cedevita sigurna protiv Igokee". b92.net (in Serbian). 2 October 2015. Retrieved 3 October 2015.
- "Katnić pojačao Igokeu, Todorović se vratio u Metalac". sportskacentrala.com (in Serbian). 9 December 2015. Retrieved 14 December 2015.
- "Nemanja Todorović još dve godine u Borcu". mozzartsport.com. Retrieved 28 July 2022.